Strategies for rapidly and inexpensively identifying neurological/psychiatric weakness and distortion - combined with genomics and increasingly more sophisticated chemical analyses of blood and other body fluids - now provide us with simple, scalable strategies for delineating specific aspects of preclinical stages of neurological and psychiatric disorders. In parallel, we have an increasing understanding of how to engage the plastic brain in ways that reverse those weaknesses and distortions on a path to neurological normalcy. The word for broadly achieving such renormalization is prevention - or in already diagnosed patients, cure - two goals that up to now have rarely been achieved in brain-targeted medicine. This scientific explosion foretells a rapid transformation from a treatment-based to prevention-based brain medicine era.
Speaker: Dr. Michael Merzenich, UC San Francisco, emeritus; Robert Lee Kilpatrick, Commonwealth Club, Moderator
Attend in person or online
Contact:Website: Click to Visit
Save this Event:iCalendar
Windows Live Calendar